Quantinno Capital Management LP Boosts Stock Position in Astera Labs, Inc. $ALAB

Quantinno Capital Management LP increased its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 49.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 42,150 shares of the company’s stock after purchasing an additional 14,010 shares during the quarter. Quantinno Capital Management LP’s holdings in Astera Labs were worth $4,620,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of ALAB. Reflection Asset Management purchased a new position in shares of Astera Labs during the fourth quarter valued at approximately $25,000. Smartleaf Asset Management LLC boosted its holdings in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after acquiring an additional 152 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new stake in Astera Labs in the fourth quarter valued at $33,000. Whipplewood Advisors LLC increased its position in Astera Labs by 15,950.0% during the 1st quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after purchasing an additional 319 shares during the period. Finally, Assetmark Inc. increased its position in Astera Labs by 78.9% during the 4th quarter. Assetmark Inc. now owns 229 shares of the company’s stock valued at $38,000 after purchasing an additional 101 shares during the period. Institutional investors own 60.47% of the company’s stock.

Insider Buying and Selling

In related news, CEO Jitendra Mohan sold 111,214 shares of the stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $216.89, for a total transaction of $24,121,204.46. Following the sale, the chief executive officer directly owned 3,817,969 shares of the company’s stock, valued at approximately $828,079,296.41. This represents a 2.83% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 14,076 shares of the firm’s stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $231.78, for a total transaction of $3,262,535.28. Following the sale, the general counsel owned 104,139 shares of the company’s stock, valued at approximately $24,137,337.42. This represents a 11.91% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 1,244,395 shares of company stock worth $358,865,571 over the last quarter. 10.40% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Susquehanna raised their target price on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research report on Friday, July 31st. Stifel Nicolaus boosted their price target on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research report on Wednesday, June 24th. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. Needham & Company LLC raised their price objective on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a report on Wednesday. Finally, TD Cowen cut their price objective on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research report on Wednesday. Thirteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $325.25.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs reported record second-quarter revenue of $392.4 million, up 104.5% year over year, while adjusted EPS of $0.80 exceeded the $0.69 consensus estimate. PCIe 6 products generated more than half of sales, highlighting strong demand for connectivity infrastructure used in AI data centers. Astera Labs Q2 Earnings Beat on PCIe 6 and Scorpio Strength
• Positive Sentiment: Management’s third-quarter outlook implies roughly 40% sequential revenue growth and came in above expectations. The Scorpio X-Series switch has entered volume production ahead of schedule, providing another potential growth driver as AI rack-scale deployments expand. ALAB Q2 Earnings Call Puts Scorpio Ramp Ahead of Schedule
• Positive Sentiment: Analysts raised their forecasts after the report. Needham lifted its price target to $425 and retained a Buy rating, while Roth MKM also assigned a Buy rating, signaling confidence in Astera Labs’ AI-connectivity opportunity. Needham Raises Astera Labs Price Target
• Neutral Sentiment: The investment thesis remains tied to selling connectivity “picks and shovels” for rising AI infrastructure spending, but investors are increasingly focused on execution and the sustainability of rapid growth.
• Negative Sentiment: Shares pulled back despite the earnings beat, likely reflecting profit-taking and valuation concerns. With a price-to-earnings ratio above 200 and shares well below their 52-week high, expectations are elevated, leaving limited room for execution setbacks. Astera Labs Post-Earnings Pullback
• Negative Sentiment: Seeking Alpha downgraded the stock, arguing that much of the easy upside may already be reflected in the price. UBS maintained a Hold rating, reinforcing the view that strong fundamentals must continue to justify ALAB’s premium valuation.

Astera Labs Trading Up 4.1%

Shares of NASDAQ:ALAB opened at $331.50 on Friday. The stock has a fifty day simple moving average of $360.62 and a two-hundred day simple moving average of $234.58. The stock has a market capitalization of $56.82 billion, a price-to-earnings ratio of 164.11, a PEG ratio of 3.69 and a beta of 3.84. Astera Labs, Inc. has a 12-month low of $97.89 and a 12-month high of $499.48.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 20.46% and a net margin of 30.74%.The firm had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the prior year, the firm posted $0.44 earnings per share. The company’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts predict that Astera Labs, Inc. will post 1.86 EPS for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.